Brokerage Firm Rating on Thermo Fisher Scientific Inc (TMO)

Thermo Fisher Scientific Inc (TMO) : 14 analysts are covering Thermo Fisher Scientific Inc (TMO) and their average rating on the stock is 1.46, which is read as a Strong Buy. 11 equity analysts believe that the stock has a bright future and the price doesnt capture all of its upside, hence they rate the stock as a Strong Buy. Thermo Fisher Scientific Inc (TMO) also receives 1 more Buy recommendations from analysts who believe that the stock will do well going forward. A Zacks Investment Research rank of 3, which recommends a Hold affirms that they expect a large upside in the stock from the current levels. However, 1 analysts consider that the stock has more downward risks ahead, hence, they suggest a Strong Sell on the stock. A total of 1 brokerage firms believe that the stock is fairly valued, hence they advise a Hold on the stock.

Thermo Fisher Scientific Inc (TMO) : The highest level Thermo Fisher Scientific Inc (TMO) is projected to reach is $177 for the short term and the lowest estimate is at $105. The consolidated price target from 10 rating analysts who initiate coverage on the stock is $162 and the possibility the share price can swing is $20.99.


For the current week, the company shares have a recommendation consensus of Buy. Thermo Fisher Scientific Inc (NYSE:TMO): During Thursdays trading session, Bulls were in full control of the stock right from the opening. The stock opened at $156.24 and $155.84 proved to be the low of the day. Continuous buying at higher levels pushed the stock towards an intraday high of $157.55. The buying momentum continued till the end and the stock did not give up its gains. It closed at $157.46, notching a gain of 0.93% for the day. The total traded volume was 781,149 . The stock had closed at $156.01 on the previous day.

In a related news, Loewald Thomas W, officer (Senior Vice President) of Thermo Fisher Scientific Inc., unloaded 8,025 shares at an average price of $155 on July 13, 2016. The total amount of the transaction was worth $1,243,875, according to the disclosed information with the Securities and Exchange Commission in a Form 4 filing.

Thermo Fisher Scientific Inc. is a provider of analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. The company operates through four segments: Life Sciences Solutions, provides reagents, instruments and consumables used in biological and medical research, discovery and production of new drugs and vaccines as well as diagnosis of disease; Analytical Instruments, provides instruments, consumables, software and services that are used in the laboratory; Specialty Diagnostics, offers diagnostic test kits, reagents, culture media, instruments and associated products, and Laboratory Products and Services, offers self-manufactured and sourced products for the laboratory.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *

Get Pre-Market Alerts!

Get Pre-Market Analysts' Upgrades, Downgrades, Earnings & Initiations with our FREE daily email newsletter.